Data Mining in Drug Discovery

by ; ; ; ; ; ;
  • ISBN13:


  • ISBN10:


  • Edition: 1st
  • Format: Hardcover
  • Copyright: 12/4/2013
  • Publisher: VCH PUBLISHER INC
  • Purchase Benefits
  • Free Shipping On Orders Over $59!
    Your order must be $59 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $196.00 Save up to $5.88
  • Buy New
    Add to Cart Free Shipping


Supplemental Materials

What is included with this book?

  • The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
  • The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.


Written for drug developers rather than computer scientists, this monograph adopts a systematic approach to mining scientifi c data sources, covering all key steps in rational drug discovery, from compound screening to lead compound selection and personalized medicine. Clearly divided into four sections, the first part discusses the different data sources available, both commercial and non-commercial, while the next section looks at the role and value of data mining in drug discovery. The third part compares the most common applications and strategies for polypharmacology, where data mining can substantially enhance the research effort. The final section of the book is devoted to systems biology approaches for compound testing.
Throughout the book, industrial and academic drug discovery strategies are addressed, with contributors coming from both areas, enabling an informed decision on when and which data mining tools to use for one's own drug discovery project.

Author Biography

Remy Hoffmann studied Pharmacy at the University Louis Pasteur in Strasbourg (France). He then graduated in Medicinal Chemistry under Prof. C. G. Wermuth. After joining BioCAD in 1992 as a support scientist for the pharmacophore perception tool CATALYST in Europe, Dr. Hoffmann joined the new company Accelrys. Dr Hoffman's main areas of interest are in lead finding (screening, pharmacophore perception) and lead optimisation (QSAR).

Table of Contents

Databases of Organic Compounds
Protein Databases
Databases for Protein-Protein Interactions
Combining Chemistry and Biology
Ontologies and Data Mining
Chemistry and Biology 1: Knime
Chemistry and Biology 2: Accelrys
Chemistry and Biology 3: Inforsense
Chemistry and Biology 4: Tibco/Spotfire
Statistical Tools and Open Source Codes for Medicinal Chemistry: R, Weka, Rapid Miner
Discovery/Polypharmacology 1: Tripos
Discovery/Polypharmacology 2: Ariana Pharma
Data Mining and Screening
Exploiting Systems Chemical Biology to Predict and Understand (Un)desired Drug Effects
High Throughput Computational Biology
Translational Medicine and Personalized Medicine

Rewards Program

Write a Review